143 related articles for article (PubMed ID: 34694160)
1. Development and Validation of an Improved Pathological Nodal Staging System in Men with Prostate Cancer.
Daskivich TJ; Luu M; Freedland SJ; Sandler H; Spratt DE; Zumsteg ZS
J Urol; 2022 Mar; 207(3):581-591. PubMed ID: 34694160
[TBL] [Abstract][Full Text] [Related]
2. Development and Validation of an Improved Pathological Nodal Staging System for Urothelial Carcinoma of the Bladder.
Patel DN; Luu M; Zumsteg ZS; Daskivich TJ
Eur Urol Oncol; 2019 Nov; 2(6):656-663. PubMed ID: 31412014
[TBL] [Abstract][Full Text] [Related]
3. Analysis of the surgical approach in prostate cancer staging: results from the surveillance, epidemiology and end results program.
da Luz FAC; Nascimento CP; da Costa Marinho E; Felicidade PJ; Antonioli RM; de Araújo RA; Silva MJB
Sci Rep; 2023 Jun; 13(1):9949. PubMed ID: 37336940
[TBL] [Abstract][Full Text] [Related]
4. Quantitative metastatic lymph node burden and survival in Merkel cell carcinoma.
Nguyen AT; Luu M; Lu DJ; Hamid O; Mallen-St Clair J; Faries MB; Gharavi NM; Ho AS; Zumsteg ZS
J Am Acad Dermatol; 2021 Feb; 84(2):312-320. PubMed ID: 31954753
[TBL] [Abstract][Full Text] [Related]
5. Adequate lymph node dissection is essential for accurate nodal staging in intrahepatic cholangiocarcinoma: A population-based study.
Zhu J; Liu C; Li H; Ren H; Cai Y; Lan T; Wu H
Cancer Med; 2023 Apr; 12(7):8184-8198. PubMed ID: 36645113
[TBL] [Abstract][Full Text] [Related]
6. Development and Validation of a Modified Pathologic Nodal Classification System for Cutaneous Melanoma.
Nguyen AT; Luu M; Nguyen VP; Hamid O; Faries MB; Gharavi NM; Lu DJ; Mallen-St Clair J; Ho AS; Zumsteg ZS
JAMA Surg; 2021 Nov; 156(11):e214298. PubMed ID: 34468697
[TBL] [Abstract][Full Text] [Related]
7. Association of Quantitative Metastatic Lymph Node Burden With Survival in Hypopharyngeal and Laryngeal Cancer.
Ho AS; Kim S; Tighiouart M; Gudino C; Mita A; Scher KS; Laury A; Prasad R; Shiao SL; Ali N; Patio C; Mallen-St Clair J; Van Eyk JE; Zumsteg ZS
JAMA Oncol; 2018 Jul; 4(7):985-989. PubMed ID: 29192305
[TBL] [Abstract][Full Text] [Related]
8. The Impact of Lymph Node Metastases Burden at Radical Prostatectomy.
Preisser F; Marchioni M; Nazzani S; Bandini M; Tian Z; Pompe RS; Montorsi F; Saad F; Abdollah F; Steuber T; Heinzer H; Huland H; Graefen M; Tilki D; Karakiewicz PI
Eur Urol Focus; 2019 May; 5(3):399-406. PubMed ID: 29306731
[TBL] [Abstract][Full Text] [Related]
9. Development of a novel salivary gland cancer lymph node staging system.
Aro K; Ho AS; Luu M; Kim S; Tighiouart M; Clair JM; Yoshida EJ; Shiao SL; Leivo I; Zumsteg ZS
Cancer; 2018 Aug; 124(15):3171-3180. PubMed ID: 29742277
[TBL] [Abstract][Full Text] [Related]
10. The Effect of Lymph Node Dissection in Metastatic Prostate Cancer Patients Treated with Radical Prostatectomy: A Contemporary Analysis of Survival and Early Postoperative Outcomes.
Mazzone E; Preisser F; Nazzani S; Tian Z; Bandini M; Gandaglia G; Fossati N; Montorsi F; Graefen M; Shariat SF; Saad F; Briganti A; Karakiewicz PI
Eur Urol Oncol; 2019 Sep; 2(5):541-548. PubMed ID: 31411992
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of patients with pelvic lymph node (LN) metastasis after radical prostatectomy: value of extranodal extension and size of the largest LN metastasis.
Passoni NM; Fajkovic H; Xylinas E; Kluth L; Seitz C; Robinson BD; Rouprêt M; Chun FK; Lotan Y; Roehrborn CG; Crivelli JJ; Karakiewicz PI; Scherr DS; Rink M; Graefen M; Schramek P; Briganti A; Montorsi F; Tewari A; Shariat SF
BJU Int; 2014 Oct; 114(4):503-10. PubMed ID: 24053552
[TBL] [Abstract][Full Text] [Related]
12. Concurrent prognostic utility of lymph node count and lymph node density for men with pathological node-positive prostate cancer.
Masterson JM; Luu M; Naser-Tavakolian A; Freedland SJ; Sandler H; Zumsteg ZS; Daskivich TJ
Prostate Cancer Prostatic Dis; 2023 Jan; ():. PubMed ID: 36600045
[TBL] [Abstract][Full Text] [Related]
13. Does increasing the nodal yield improve outcomes in contemporary patients without nodal metastasis undergoing radical prostatectomy?
Kluth LA; Xylinas E; Rieken M; Chun FK; Fajkovic H; Becker A; Karakiewicz PI; Passoni N; Herman M; Lotan Y; Seitz C; Schramek P; Remzi M; Loidl W; Guillonneau B; Rouprêt M; Briganti A; Scherr DS; Graefen M; Tewari AK; Shariat SF
Urol Oncol; 2014 Jan; 32(1):47.e1-8. PubMed ID: 24055425
[TBL] [Abstract][Full Text] [Related]
14. Two positive nodes represent a significant cut-off value for cancer specific survival in patients with node positive prostate cancer. A new proposal based on a two-institution experience on 703 consecutive N+ patients treated with radical prostatectomy, extended pelvic lymph node dissection and adjuvant therapy.
Briganti A; Karnes JR; Da Pozzo LF; Cozzarini C; Gallina A; Suardi N; Bianchi M; Freschi M; Doglioni C; Fazio F; Rigatti P; Montorsi F; Blute ML
Eur Urol; 2009 Feb; 55(2):261-70. PubMed ID: 18838212
[TBL] [Abstract][Full Text] [Related]
15. Topography of lymph node metastases in prostate cancer patients undergoing radical prostatectomy and extended lymphadenectomy: results of a combined molecular and histopathologic mapping study.
Heck MM; Retz M; Bandur M; Souchay M; Vitzthum E; Weirich G; Mollenhauer M; Schuster T; Autenrieth M; Kübler H; Maurer T; Thalgott M; Herkommer K; Gschwend JE; Nawroth R
Eur Urol; 2014 Aug; 66(2):222-9. PubMed ID: 23465520
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of histomorphologic features of lymph node metastases in prostate cancer patients treated with radical prostatectomy: A single center study.
Alhamar M; Jabbar A; Deebajah M; Diaz M; Alanee S; Hassan O; Williamson SR; Schultz D; Gupta N
Urol Oncol; 2021 Dec; 39(12):829.e1-829.e8. PubMed ID: 33985876
[TBL] [Abstract][Full Text] [Related]
17. Small-volume lymph node involvement and biochemical recurrence after robot-assisted radical prostatectomy with extended lymph node dissection in prostate cancer.
Morizane S; Honda M; Shimizu R; Teraoka S; Nishikawa R; Tsounapi P; Kimura Y; Iwamoto H; Hikita K; Takenaka A
Int J Clin Oncol; 2020 Jul; 25(7):1398-1404. PubMed ID: 32333202
[TBL] [Abstract][Full Text] [Related]
18. Significance of examined lymph-node count in accurate staging and long-term survival in patients undergoing radical prostatectomy: a population-based study.
Chen C; Shen J; Xing Z; Jiang C; Hu L; Cui L; Xue D; He X; Xu R
Int Urol Nephrol; 2020 Feb; 52(2):271-278. PubMed ID: 31571158
[TBL] [Abstract][Full Text] [Related]
19. How accurate is
Erdem S; Simsek DH; Degirmenci E; Aydin R; Bagbudar S; Ozluk Y; Sanli Y; Sanli O; Ozcan F
Urol Oncol; 2022 Jan; 40(1):6.e1-6.e9. PubMed ID: 34400066
[TBL] [Abstract][Full Text] [Related]
20. Differing risk of cancer death among patients with lymph node metastasis after radical prostatectomy and pelvic lymph node dissection: identification of risk categories according to number of positive nodes and Gleason score.
Schiavina R; Borghesi M; Brunocilla E; Manferrari F; Fiorentino M; Vagnoni V; Baccos A; Pultrone CV; Rocca GC; Rizzi S; Martorana G
BJU Int; 2013 Jun; 111(8):1237-44. PubMed ID: 23331345
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
